In Vivo Engraftment Potential of Clinical Hematopoietic Grafts

Journal of Investigative Medicine

Volumn 46, Issue 6, 1998, Pages 303-311

  Leung, Wing ^a,b   Ramírez, Manuel ^a   Novelli, Enrico M ^a   Civin, Curt I ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

Biological assays; Hematopoietic stem cell transplantation; Human; Mice SCID; Statistics

Indexed keywords

CUCURBITA;

CD19 ANTIGEN; CD34 ANTIGEN; MICROSOMAL AMINOPEPTIDASE;

ADULT; ANIMAL; ARTICLE; B LYMPHOCYTE; CHIMERA; COMPARATIVE STUDY; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE DEPLETION; MOUSE; MOUSE MUTANT; NONOBESE DIABETIC MOUSE; T LYMPHOCYTE; TRANSPLANTATION; XENOGRAFT;

ADULT; ANIMALS; ANTIGENS, CD13; ANTIGENS, CD19; ANTIGENS, CD34; B-LYMPHOCYTES; CHIMERA; GRAFT ENHANCEMENT, IMMUNOLOGIC; GRAFT SURVIVAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED NOD; MICE, SCID; T-LYMPHOCYTES; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HETEROLOGOUS;

EID: 0032135529     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Appelbaum FR. Allogeneic stem cells transplantation for the treatment of hematologic malignancies: current indications and challenges. J. Rheumatol 1997;48:41-5.
2. Territo M. The use of autologous transplantation in the treatment of malignant disorders. J. Rheumatol 1997;48:36-40.
3. Storb R. Hematopoietic stem cell transplantation in nonmalignant diseases. J Rheumatol 1997;48:30-5.
4. Flake AW, Zanjani ED. In utero hematopoietic stem cell transplantation. JAMA 1997;278:932-7.
5. Collins N.A, Gee A, Rowley S, Shpall E. Are we ready for regulation? ISHAGE Regulatory Action Group. International Society for Hematotherapy and Graft Engineering. J. Hematother 1995;4:1-2.
6. Sutherland HJ, Hogge DE PML, Phillips GL, Eaves AC, Eaves CJ. Quantitation, mobilization, and clinical use of long-term culture-initiating cells in blood cell autografts. J Hematother 1995;4:3-10.
7. Pflumio F, Izac B, Katz A, Shultz LD, Vainchenker W, Coulombel L. Phenotype and function of human hematopoietic cells engrafting immune-deficient CB17-severe combined immunodeficiency mice and nonobese diabetic-severe combined immunodeficiency mice after transplantation of human cord blood mononuclear cells. Blood 1996;88:3731-40.
8. Wang JCY, Doedens M, Dick JE. Primitive human hematopoietic cells are enriched in cord blood compared with adult bone marrow or mobilized peripheral blood as measured by the quantitative in vivo SCID-repopulating cell assay. Blood 1997;89:3919-24.
9. Conneally E, Cashman J, Petzer A, Eaves C. Expansion in vitro of transplantable human cord blood stem cells demonstrated using a quantitative assay of their lymphoid-myeloid repopulating activity in nonobese diabetic-scid/scid mice. Proc Natl Acad Sci 1997;94:9836-41.
10. Leung W, Chen AR,. Civin CI. Use of purified stem and progenitor cells for transplantation. In: Atkinson K, ed. Clinical Bone Marrow Transplantation. Cambridge: Cambridge University Press, 1998. In press.
11. Martin PJ, Horowitz MM.T cell depletion of donor marrow. In: Atkinson K, ed. Clinical Bone Marrow Transplantation. Cambridge: Cambridge University Press, 1994;653-7.
12. Piantadosi S. Factorial designs. In: Piantadosi S, ed. Clinical trials: a methodologic approach. New York: John Wiley & Sons, 1997;385-400.
13. Gluckman E, Rocha V, Boyer-Chammard A, Locatelli F, Arcese W, Pasquini R, Ortega J, Souillet G, Ferreira E, Laporte J, Fernandez M, Chastang C. Outcome of cord blood transplantation from related and unrelated donors. N Engl J Med 1997;337:373-81.
14. Mavroudis D, Read E, Cottier-Fox M, Couriel D, Molldrem J, Carter C, Yu M, Dunbar C, Barrett J. CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies. Blood 1996;88:3223-9.
15. Korbling M, Huh YO, Durett A, Mireza N, Miller P, Engel H, Anderlini P, Van Besien K, Andreeff M, Przepiorka D, Deisseroth AB, Champlin RE. Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1 dim) and lymphoid subsets, and possible predictors of engraftments and graft-versus-host disease. Blood 1995;86:2842-8.
16. Hulley SB, Cummings SR. Total sample size required when using the correlation coefficient. In: Hulley SB, Cummings SR, eds. Designing Clinical Research. Baltimore: Williams & Wilkins, 1988:218.
17. Shultz LD, Schweitzer PA, Christianson SW, Gott B, Schweitzer IB, BT, McKenna S, Mobraaten L, Rajan TV, Greiner DL, Leiter EH. Multiple defects in innate and adaptive immunologic function in NOD/LtSz-scid mice. J Immunol 1995;154:180-91.
18. Cohen J. Statistical power analysis for the behavioral sciences. Hillsdale, NJ. 1988.
19. Passos-Coelho JL, Ross AA, Moss TJ, Davis JM, Huelskamp A, Noga ST. Davidson NE, Kennedy MJ. Absence of breast cancer cells in single-day peripheral blood progenitor cell collection after priming with Cyclophosphamide and granulocyte-macrophage colony-stimulating factor. Blood 1995;85:1138.
20. Civin CI, Almeida-Porada G, Lee MJ, Olweus J, Terstappen LWMM, Zanjani ED. Sustained, retransplantable, multilineage engraftment of highly purified adult human bone marrow stem cells in vivo. Blood 1996;88:4102-9.
21. Ramirez M, Rottman GA, Shultz LD, Civin CI. Mature human hematopoietic cells in donor bone marrow complicate interpretation of stem/progenitor cell assays in xenogeneic hematopoietic chimeras. Exp Hematol 1998;26:332-44.
22. Boggs DR. The total marrow mass of the mouse: a simplified method of measurement. Am J Hematol 1984;16:277-86.
23. Trischmann TM, Schepers KG, Civin CI. Measurement of CD34+ cells in bone marrow by flow cytometry. J Hematother 1993;2:305-13.
24. Carow CE, Harrington MA,. Broxmeyer HE. Measurement of CD34+ cells in bone marrow by flow cytometry. J. Hematother 1993;2:305-13.
25. Hocking RR. The analysis and selection of variables in linear regression. Biometrics 1976;32:1-50.
26. Draper NR, Smith H. Fitting a straight line by least squares. In: Draper NR, Smith H, eds. Applies regression analysis. New York: John Wiley & Sons, 1981;1-69.
27. Everitt BS. Repeated measures analysis of variance and the analysis of covariance. In: Everitt B, ed. Statistical methods for medical investigation. New York: Oxford University Press, 1989;57-67.
28. Wald A. The fitting of straight lines if both variables are subject to error. Ann Math Statist 1940;1:284-300.
29. Ramsey JB. Tests for specification errors in classical linear least squares regression analysis. JR Statist Soc Series 1969;31:350-71.
30. Cook RD, Weisberg S. Diagnostics for heteroscedasticity in regression. Biometrika 1983;70:1-10.
31. Wilcoxon F. Individual comparisons by ranking methods. Biometrics 1945;1:80-3.
32. Spearman C. The proof and measurement of association between two things. Am J Psychol 1904;15:72-101.
33. Harrison DE, Craig TJ, Zhong RK, Clinton MA. Primitive hematopoietic stem cells: direct assay of most productive populations by competitive repopulation with simple binomial, correlation and covariance calculations. Exp Hemato. 1993;21:206-19.
34. Atkinson K. Hematopoietic reconstitution posttransplant. In: Atkinson K. eds. Clinical Bone Marrow Transplantation. Cambridge: Cambridge University Press, 1994;31-41.
35. Weisdorf DJ, Verfaillie CM, Davies SM, Filipovich AH, Wagner Jr JE, Miller JS, Burroughs J, Ramsay NK, Kersey JH, McGlave PB. Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-marcrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF. Blood 1995;85:3452-6.
36. Schuening F, Bean MA, Deeg HJ,. Storb R. Prevention of graft failure in patients with aplastic anemia. Bone Marrow Transplant 1993;12:548-9.
37. Henslee-Downey PJ. Mismatched bone marrow transplantation. Curr Opin Oncol 1995;7:115-11.
38. Noga SJ, Vogelsang GB, Seber A, Davis JM, Schepers K, Hess AD, Jones RJ. CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporing A is still required to reduce GVHD and morbidity. Transplant Proc 1997;29:728-32.
39. Brenner MK. Gene transfer to hematopoietic cells. N Engl J Med 1996;335:337-9.
40. Bambach BJ, Moser HW, Blakemore K, Corson VL, Griffin CA, Noga SJ, Perlman EJ, Zuckerman R, Wenger DA, Jones RJ. Engraftment following in utero bone marrow transplantation for globoid cell leukodystrophy. Bone Marrow Transplant. 1997;19:399-402.
41. Orlic D, Bodine DM. What defines a pluripotent hematopoietic stem cell (PHSC): will the real PHSC please stand up. Blood 1994;84:3991-4.
42. Morrison SJ, Shah NM, Anderson DJ. Regulatory mechanisms in stem cell biology. Cell 1997;88:287-98.
43. Morrison SJ, Wandycz AM, Akashi K, Gloverson A, Weissman IL. The aging of hematopoietic stem cells. Nature Med 1996;2:202-6.
44. Morrison SJ, Prowse KR, Ho P, Weissman IL. Telomerase activity in hematopoietic cells is associated with self-renewal potential. Immunity 1996;5:207-16.
45. Mayani H, Lansdorp PM. Thy-1 expression is linked to functional properties of primitive hematopoietic progenitor cells from human umbilical cord blood. Blood 1994;83:2410-7.
46. Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM. Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci 1994;91:9857-60.
47. Vormoor J, Lapidot T, Pflumio F, Risdon G, Patterson B, Broxmeyer HE, Dick JE. Immature human cord blood progenitors engraft and proliferate to high levels in severe combined immunodeficient mice. Blood 1994;83:2489-97.
48. Hogan CJ, Shpall EJ, McNulty O, McNiece I, Dick JE, Shultz LD, Keller G. Engraftment and development of human CD34+-enriched cells from umbilical cord blood in NOD/LtSz-scid/scid mice. Blood 1997;90:85-96.
49. Nishi N, Ishikawa R, Inoue H, Nishikawa M, Kakeda M, Yoneya T, Tsumura H, Ohashi H, Yamaguchi Y, Motoki K, Sudo T, Mori KJ. Granulocyte-colony stimualting factor and stem cell factor are the crucial factors in long-term culture of human primitive hematopoietic cells supported by a murine stromal cell line. Exp Hematol 1996;24:1312-21.
50. Dawson-Saunders B, Trapp RG. Association and prediction. In: Dawson-Saunders B, Trapp RG, eds. Basic and clinical biostatistics. Norwalk, Connecticut: Appleton & Lange. 1994;164-5.